ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Rheumatology

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

20,535Medicare Part D Prescriptions Filled, Including Refills

Rank: 2 out of 416

$1.4M Total Retail Price of All Prescriptions

Rank: 21 out of 416

647 Patients Receiving at Least One Drug in Part D
91%Patients 65 Years and Older
77% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in California
Lower avg

Schedule Two
Controlled Substances

N/A

Schedule Three
Controlled Substances

9% of this provider’s 647 patients filled at least one prescription for a schedule three drug, compared to an average of 12%.

Risky Drugs to Seniors

3% of this provider’s 19,725 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

44% of this provider’s prescriptions were for brand-name drugs, compared to an average of 27%.

Prescription Price

$68 was the average price of a prescription from this provider, compared to $166 among peers.

Prescriptions per Patient

32 is the average number of prescriptions (including refills) per patient, compared to an average of 10.


This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in California
AMLODIPINE BESYLATE 1,225 1,188 1 16
SIMVASTATIN 1,026 982 2 14
ATORVASTATIN CALCIUM 828 785 3 29
EVISTA 713 710 4 55
ALENDRONATE SODIUM 702 662 5 5
OMEPRAZOLE 663 640 6 10
DIOVAN HCT 620 599 7 47
METFORMIN HCL 587 553 8 28
LOSARTAN POTASSIUM 573 533 9 33
DIOVAN 568 551 10 41
METOPROLOL SUCCINATE 472 452 11 53
LOSARTAN-HYDROCHLOROTHIAZIDE 430 414 12 65
TAMSULOSIN HCL 407 399 13 54
NEXIUM 402 401 14 31
JANUVIA 401 393 15 57
ATENOLOL 344 312 16 27
LIDODERM 283 283 17 19
DONEPEZIL HCL 270 270 18 63
LOVASTATIN 258 237 19 46
LIPITOR 253 239 20 87
ZOLPIDEM TARTRATE 246 230 21 21
GLYBURIDE 245 229 R 22 114
NATEGLINIDE 227 226 23 114
CELEBREX 223 223 24 11
BENAZEPRIL HCL 216 196 25 61
GLIPIZIDE 215 203 26 75
CLOPIDOGREL 209 209 27 70
LEVOTHYROXINE SODIUM 187 175 28 18
PLAVIX 179 179 29 74
FENOFIBRATE 176 176 30 134
NIFEDIPINE ER 157 157 31 104
MELOXICAM 151 151 32 9
DOXAZOSIN MESYLATE 143 143 33 86
DEXILANT 142 139 34 73
GLYBURIDE-METFORMIN HCL 135 135 R 35 118
ACTONEL 133 133 36 40
LANTUS SOLOSTAR 127 127 37 171
POTASSIUM CHLORIDE 119 119 38 51
BENICAR 118 111 39 123
ISOSORBIDE MONONITRATE ER 110 110 40 122
SINGULAIR 109 106 41 116
AZITHROMYCIN 105 97 42 60
HYDROCHLOROTHIAZIDE 103 94 43 36
PRAVASTATIN SODIUM 101 96 44 62
GABAPENTIN 100 100 45 6
TRILIPIX 97 86 46 215
EXFORGE 96 86 47 113
TERAZOSIN HCL 96 96 47 146
LANSOPRAZOLE 96 96 47 130
TRIAMCINOLONE ACETONIDE 93 90 50 95
CREON 90 90 51 66
NAMENDA 87 87 52 110
ZETIA 86 86 53 103
ADVAIR DISKUS 84 84 54 126
KETOCONAZOLE 83 57 55 225
TRICOR 81 74 56 170
BENAZEPRIL-HYDROCHLOROTHIAZIDE 80 79 57 187
CRESTOR 78 78 58 58
VALSARTAN-HYDROCHLOROTHIAZIDE 76 75 59 196
BENICAR HCT 75 75 60 128
NIFEDICAL XL 75 75 60 181
PANTOPRAZOLE SODIUM 74 73 62 52
AVODART 73 73 63 132
CIPROFLOXACIN HCL 71 70 64 111
AMLODIPINE BESYLATE-BENAZEPRIL 70 70 65 164
HYDROCODONE-ACETAMINOPHEN 68 59 S3 66 4
LOVAZA 67 67 67 72
RAMIPRIL 67 55 67 187
PEN NEEDLE 66 66 69 89
SPIRIVA 64 64 70 175
WELCHOL 60 60 71 247
FAMOTIDINE 59 58 72 91
MONTELUKAST SODIUM 59 55 72 166
FLUTICASONE PROPIONATE 58 57 74 93
ALLOPURINOL 57 44 75 13
VOLTAREN 56 51 76 22
TEKTURNA 56 56 76 168
ACETAMINOPHEN-CODEINE 55 55 S3 78 45
VIAGRA 55 53 78 257
IBANDRONATE SODIUM 54 54 80 80
METHOTREXATE 50 50 81 2
AMOXICILLIN 50 47 81 203
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on July 8, 2007.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.